Beam Therapeutics Inc.

NASDAQ: BEAM · Real-Time Price · USD
17.64
0.12 (0.68%)
At close: Aug 14, 2025, 3:59 PM
17.70
0.34%
Pre-market: Aug 15, 2025, 09:02 AM EDT

Beam Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-398.58M -387.34M -376.74M -143.59M -143.01M -134.74M -132.53M -313.67M -327.16M -316.33M -289.09M -315.45M -233.99M -238.29M -370.64M -401.39M -407.73M -365.69M
Depreciation & Amortization
23.18M 31.69M 31.59M 21.84M 21.56M 20.8M 20.01M 18.59M 16.88M 15.48M 14.15M 12.84M 11.11M 9.37M 7.45M 6.09M 5.56M 5.03M
Stock-Based Compensation
110.83M 118.06M 120.66M 113.06M 109.34M 104.01M 98.65M 98.53M 94.9M 90.2M 84.32M 77.32M 68.08M 56.96M 43.57M 34.88M 24.92M 17.24M
Other Working Capital
-45.1M -102.05M -112.03M -121.42M -113.12M -103.37M -108.73M -92.39M -91.59M -72.52M 244.45M 300.51M 373.82M 383.76M 110.44M 73.6M 21.74M 8.48M
Other Non-Cash Items
-33.9M 24.93M 67.31M 108.96M 106.14M 68.68M 30.57M -47.43M -40.7M -47.56M -55.23M -1.68M -13.15M -2.54M 158.86M 154.4M 168.84M 165.3M
Deferred Income Tax
n/a n/a n/a -35.26M -36.62M -49.44M -49.44M -14.18M -12.82M n/a n/a -3.18M -34.11M -18.68M -16.77M 41.18M 69.57M 62.86M
Change in Working Capital
-46.35M -97.73M -110.22M -120.98M -115.03M -109.58M -116.45M -95.3M -86.03M -64.32M 251.63M 306.94M 373.11M 383.99M 111.25M 72.45M 22.23M 8.34M
Operating Cash Flow
-344.82M -351.38M -347.25M -135.81M -137.47M -139.13M -149.19M -353.46M -338.17M -305.78M 22.53M 93.55M 171.05M 190.8M -66.27M -92.4M -116.62M -106.93M
Capital Expenditures
-10.75M -9.57M -8.95M -9.56M -15.94M -30.15M -33.73M -38.4M -42.24M -47.71M -48.95M -54.06M -48.05M -42.59M -46.81M -41.57M -38.61M -24.79M
Cash Acquisitions
n/a n/a n/a -101.69M -99.41M -74.1M -105.57M -125.58M -127.87M -173.55M -142.08M -21M -21M -620K n/a -130K -130K -130K
Purchase of Investments
-829.84M -630.37M -486.44M -539.71M -656.69M -913.05M -984.34M -1.17B -1.25B -1.19B -1.62B -1.55B -1.37B -1.18B -777.22M -721.26M -573.9M -453.11M
Sales Maturities Of Investments
696.06M 753.32M 680.39M 706.1M 794.53M 936.13M 1.09B 1.3B 1.36B 1.34B 1.2B 950.87M 877.63M 669.13M 529.27M 464.14M 272.92M 174.32M
Other Investing Acitivies
n/a 89.45M 38.43M 140.12M 137.83M 23.08M 105.57M 125.58M 103.48M 149.16M -412.38M -533.47M -427.18M -444.52M -183.21M -256.38M -300.23M -278.04M
Investing Cash Flow
-144.52M 113.38M 185.01M 156.83M 121.9M -7.08M 71.84M 87.18M 61.24M 101.45M -461.34M -652.27M -539.98M -551.86M -294.14M -298.07M -338.96M -302.96M
Debt Repayment
-201K -308K -485K -1.12M -1.32M -1.83M -2.25M -2.21M -2.39M -2.34M -2.29M -2.24M -2.19M -2.14M -2.12M -345K -226K -141K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
476.43M 5.9M 6.76M 4.06M 6.29M 6.57M 8.53M 11.57M 11.48M 11.51M 8.7M 6.75M 7.1M 9.23M 810K 713K -1.27M -4.29M
Financial Cash Flow
479.19M 478.22M 7.74M 38.01M 73.52M 180.93M 276.45M 274.75M 239.53M 154.33M 111.59M 101.12M 420.44M 558.54M 756.14M 864.59M 543.8M 382.58M
Net Cash Flow
-4M 246.67M -145.78M 67.7M 60.48M 36.95M 199.05M 8.47M -37.4M -49.99M -327.22M -457.6M 51.51M 197.49M 395.73M 474.12M 88.22M -27.3M
Free Cash Flow
-355.57M -360.96M -356.19M -145.37M -153.4M -169.28M -182.93M -391.86M -380.41M -353.49M -26.42M 39.49M 123M 148.21M -113.08M -133.96M -155.22M -131.72M